Literature DB >> 6526540

Circadian bioavailability and some effects of propranolol in healthy subjects and in liver cirrhosis.

K Semenowicz-Siuda, A Markiewicz, J Korczyńska-Wardecka.   

Abstract

The aim of the study was to establish whether and how circadian rhythms alter the bioavailability of, and response of circulatory and ventilatory functions to 80 mg of propranolol given at four different test times. Both Cmax and AUC were lowest at 2:00 pm as compared with other test times in healthy group (N = 6), lower in cirrhosis (N = 6), but none in portacaval shunt (N = 3). Thus, at 2:00 pm, liver extraction seems to be the best in healthy subjects, worse in cirrhotics and negligible in PC shunt. The mean AUC value in PC shunt patients was three times as high as in healthy subjects and cirrhotics. This seems to be due to the reduced first-pass extraction phenomenon in the liver in PC cases. All subjects exhibited a prompt and significant depression of radial pulse and systolic BP; this effect on radial pulse was lasting longer at 2:00 am than at other test times. The initial values of PEF were lowest at 2:00 am and no depressing effect of propranolol was observed in comparison with other test times. From the practical point of view, the changeable bioavailability of propranolol given at different times of the day has no direct consequences in regards to the temporal response to the drug in healthy subjects and cirrhotics, since it is likely that both propranolol and its metabolites (4-OHP) are active as beta-blockers. Twenty-four hour oscillations of the responses to propranolol seem to exist both in healthy and cirrhotic patients.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6526540

Source DB:  PubMed          Journal:  Int J Clin Pharmacol Ther Toxicol        ISSN: 0174-4879


  4 in total

1.  Clinical chronopharmacology of oral sustained-release isosorbide-5-mononitrate in healthy subjects.

Authors:  B Lemmer; B Scheidel; H Blume; H J Becker
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

2.  Circadian changes in the pharmacokinetics and cardiovascular effects of oral propranolol in healthy subjects.

Authors:  B Langner; B Lemmer
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

3.  Circadian influence on effect of propranolol on exercise-induced tachycardia in healthy subjects.

Authors:  A Fujimura; Y Kumagai; K Sugimoto; H Nakashima; H Kajiyama; A Ebihara; K Ohashi
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing.

Authors:  S W Sanders; N Haering; H Mosberg; H Jaeger
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.